Journal of Pediatric and Adolescent Gynecology
Volume 19, Issue 3 , Pages 173-179 , June 2006

Usefulness of Monitoring Fertility from Menarche

  • Pilar Vigil, MD, PhD

      Affiliations

    • Unit of Reproduction and Development, Faculty of Biological Sciences, Pontifical Catholic University of Chile, Santiago, Chile
    • Fundación Médica San Cristóbal, Santiago, Chile
    • Corresponding Author InformationAddress correspondence to: Pilar Vigil, MD, PhD, Unit of Reproduction and Development, Faculty of Biological Sciences, Pontifical Catholic University of Chile, Av. Alameda O'Higgins 340, Santiago, Chile
  • ,
  • Francisco Ceric, PhD

      Affiliations

    • Unit of Reproduction and Development, Faculty of Biological Sciences, Pontifical Catholic University of Chile, Santiago, Chile
    • School of Psychology, Faculty of Social Sciences, Pontifical Catholic University of Chile, Av. Vicuña Mackenna 4860, Santiago, Chile
  • ,
  • Manuel E. Cortés

      Affiliations

    • Unit of Reproduction and Development, Faculty of Biological Sciences, Pontifical Catholic University of Chile, Santiago, Chile
  • ,
  • Hanna Klaus, MD

      Affiliations

    • TeenSTAR Program, Natural Family Planning Center of Washington, D.C. 8514 Bradmoor Drive, Bethesda, MD 20817-3810, USA

References 

  1. Lunenfeld B, Insler V. Follicular development and its control. Gynecol Endocrinol. 1993;7:285
  2. Roche JF. Control and regulation of folliculogenesis—a symposium in perspective. Rev Reprod. 1996;1:19
  3. Vigil P, Rodríguez-Rigau L, Palacios X, et al. Diagnosis of menstrual disorders in adolescence. In:  Frajese G,  Steinberger E,  Rodríguez-Rigau LJ editor. Reproductive Medicine. New York: Raven Press; 1993;p. 149–154
  4. Brown JB, Blackwell LF, Holmes J, et al. New assays for identifying the fertile period. Int J Gynecol Obstet. 1989;Suppl 1:111
  5. Blackwell LF, Brown JB, Cooke DG. Definition of the potentially fertile period from urinary steroid excretion rates. Part II. A threshold value for pregnanediol glucuronide as a marker for the end of the potentially fertile period in the human menstrual cycle. Steroids. 1998;63:5
  6. Brown J: Ovarian activity and fertility and the Billings ovulation method. In: Studies on Human Reproduction. Melbourne, Ovul Meth Res Ref Centre Australia, 2000. Available: http://www.woomb.org/bom/science/ovarian.html. Accessed 4/10/2005.
  7. Miro F, Aspinall LJ. The onset of the initial rise in follicle-stimulating hormone during the human menstrual cycle. Hum Reprod. 2005;20:96
  8. Catt KJ, Pierce JG. Gonadotropin hormones of the adenohypophysis. In: Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management. Edited by SSC Yen, RB Jaffe. Philadelphia: W.B. Saunders; 1978;p. 75–113
  9. Blackwell LF, Brown JB, Vigil P, et al. Hormonal monitoring of ovarian activity using the ovarian monitor. Part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay. Steroids. 2003;68:465
  10. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril. 1950;1:3
  11. Johannisson E, Oberholzer M, Swahn ML, et al. Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486. Contraception. 1989;39:103
  12. Barros C, Arguello B, Jedlicki A, et al. Scanning electron microscopy study of human cervical mucus. Gam Res. 1985;12:85
  13. Morales P, Rocco M, Vigil P. Human cervical mucus: relationship between biochemical characteristics and ability to allow migration of spermatozoa. Hum Reprod. 1993;8:78
  14. Vigil P, Pérez A, Neira J, et al. Post-partum cervical mucus: biological and rheological properties. Hum Reprod. 1991;6:457
  15. Armstrong DG, Webb R. Ovarian follicular dominance: the role of intraovarian growth factors and novel proteins. Rev Reprod. 1997;2:139
  16. Laven JS, Fauser BC. Inhibins and adult ovarian function. Mol Cell Endocrinol. 2004;225:37
  17. Hoff JD, Quiglel ME, Yen SS. Hormonal dynamics at midcycle: a reevaluation. J Clin Endocrinol Metab. 1983;57:792
  18. Ferin MD, Van Vugt D, Warlaw S. The hypothalamic control of the menstrual cycle and the endogenous opioid peptides. Rec Prog Horm Res. 1984;40:441
  19. Miyake A, Kawamura Y, Aono T, et al. Changes in plasma LRH during the normal menstrual cycle in women. Acta Endocrinol (Copenh). 1980;93:257
  20. Misao R, Nakanishi Y, Iwagaki S, et al. Expression of progesterone receptor isoforms in corpora lutea of human subjects: correlation with serum estrogen and progesterone concentrations. Mol Hum Reprod. 1998;4:1045
  21. Elstein M, Daunter B: The structure of cervical mucus. In: The Cervix. Edited by JA Jordan, A Singer. London, W.B. Saunders, 1976
  22. Odeblad E, Ingelman-Sundberg A, Hallström L, et al. The biophysical properties of cervical-vaginal secretions. Int Rev Nat Fam Plann. 1983;7:1
  23. Vollman RF: The menstrual cycle. In: Major Problems in Obstetrics and Gynecology, (1st ed.). Edited by EA Friedman. Toronto, W.B. Saunders, 1977, pp 11–193
  24. Yen SSC, Tsai CC. The biphasic pattern in the feedback action ethynyl estradiol on the release of FSH and LH. J Clin Endocrinol Metab. 1971;33:882
  25. Lincoln DW, Fraser HM, Lincoln GA. Hypothalamic pulse generators. Rec Prog Horm Res. 1985;41:369
  26. Yen SSC: The human menstrual cycle. In: Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management, (2nd ed.). Edited by SSC Yen, RB Jaffe. Philadelphia, W.B. Saunders, 1991, pp 273–308
  27. Brown JB, Blackwell LF, Billings JJ, et al. Natural family planning. Am J Obstet Gynecol. 1987;157:1082
  28. Blackwell LF, Brown JB. Application of time-series analysis for the recognition of increases in urinary estrogens as markers for the beginning of the potentially fertile period. Steroids. 1992;57:554
  29. Moniaux N, Escande F, Porchet N, et al. Structural organization and classification of the human mucin genes. Front Biosci. 2001;6:D1192
  30. Ceric F, Silva D, Vigil P. Ultrastructure of the human periovulatory cervical mucus. J Electron Microsc (Tokyo). 2005;54:479
  31. Gipson IK, Moccia R, Spurr-Michaud S, et al. The amount of MUC 5B mucin in cervical mucus peaks at midcycle. J Clin Endocrinol Metab. 2001;86:594
  32. Gipson IK, Spurr-Michaud S, Moccia R, et al. MUC4 and MUC5B transcripts are the prevalent mucin messenger ribonucleic acids of the human endocervix. Biol Reprod. 1999;60:58
  33. Gipson IK. Mucins of the human endocervix. Front Biosci. 2001;6:1245
  34. Barbieri RL: Infertility. In: Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management (4th ed.). Edited by SSC Yen, RB Jaffe. Philadelphia, W.B. Saunders, 1999, pp 562–593
  35. Billings EL, Billings JJ, Catarinich M. Billings Atlas of the Ovulation Method. The Mucus Patterns of Fertility and Infertility. Melbourne: Advocate Press; 1989;pp 1–108
  36. Vigil P. La Fertilidad de la Pareja Humana. Santiago de Chile: Ediciones Universidad Católica de Chile; 2004;pp 71–76
  37. Ceric F, Riquelme R, Pinto E, et al. Scanning electron microscopy study of cervical mucus during the periovulatory period. J Physiol (Lond). 2000;523:125P
  38. Gipson IK, Ho SB, Spurr-Michaud SJ, et al. Mucin genes expressed by human female reproductive tract epithelia. Biol Reprod. 1997;56:999
  39. Billings EL, Billings JJ, Brown JB, et al. Symptoms and hormonal changes accompanying ovulation. Lancet. 1972;1:282
  40. Klaus H. Natural family planning: a review. Obstet Gynecol Surv. 1982;37:128
  41. Klaus H, Martin JL. Recognition of ovulatory/anovulatory cycle pattern in adolescents by mucus self-detection. J Adolesc Health Care. 1989;10:93
  42. Mansfield MJ, Emans SJ. Anorexia nervosa, athletics, and amenorrhea. Pediatr Clin North Am. 1989;36:533
  43. Diddle AW. Athletic activity and menstruation. South Med J. 1983;76:619
  44. Barron ML. Proactive management of menstrual cycle abnormalities in young women. J Perinat Neonatal Nurs. 2004;18:81
  45. Clark R. The somatogenic hormones and insulin-like growth factor I: stimulators of lymphopoiesis and immune function. Endocr Rev. 1997;18:157
  46. Johansson GG, Karonen SL, Laakso ML. Reversal of an elevated plasma level of prolactin during prolonged psychological stress. Acta Physiol Scand. 1983;119:463
  47. Vigil P, Steinberger E, del Río MJ, et al. Síndrome de ovario poliquístico. In:  Guzmán E editors. Selección de Temas en Ginecoobstetricia. Santiago de Chile: Editorial Publimpacto; 2005;p. 833–842
  48. Vigil P, Kolbach M, Aglony M, et al. Hiperandrogenismo e irregularidades menstruales en mujeres jóvenes. Rev Chil Obst Ginecol. 1999;64:389
  49. Van Hooff MHA, Voorhorst FJ, Kaptein MB, et al. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligomenorrhoea at age 18 years. Hum Reprod. 2004;19:383
  50. Koutras DA. Disturbances of menstruation in thyroid disease. Ann NY Acad Sci. 1997;816:280
  51. Howe L, Wiggins R, Soothill PW, et al. Mucinase and sialidase activity of the vaginal microflora: implications for the pathogenesis of preterm labour. Int J STD AIDS. 1999;10:442
  52. Stadtmauer LA, Wong BC, Oehninger S. Should patients with polycystic ovary syndrome be treated with metformin? Benefits of insulin sensitizing drugs in polycystic ovary syndrome beyond ovulation induction. Hum Reprod. 2002;17:3016
  53. Vigil P, Morales P, Tapia A, et al. Chlamydia trachomatis infection in male partners of infertile couples: Incidence and sperm function. Andrologia. 2002;34:155
  54. Olmsted SS, Padgett JL, Yudin AI, et al. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J. 2001;81:1930
  55. Pinkerton GD, Carey HM. Post-pill anovulation. Med J Aust. 1976;8:220
  56. Linn S, Schoenbaum SC, Monson RR, et al. Delay in conception for former ‘pill’ users. JAMA. 1982;247:629
  57. Kolstad HA, Bonde JP, Hjøllund NH, et al. Menstrual cycle pattern and fertility: a prospective follow-up study of pregnancy and early embryonal loss in 295 couples who were planning their first pregnancy. Fertil Steril. 1999;71:490
  58. Gnoth C, Frank-Herrmann P, Schmoll A, et al. Cycle characteristics after discontinuation of oral contraceptives. Gynecol Endocrinol. 2002;16:307
  59. Steinberger E, Rodríguez-Rigau LJ, Ayala C, et al: Consequences of hyperandrogenism during adolescence on the ovarian function of adult female. In: Reproductive Medicine. Edited by G Frajese, E Steinberger, LJ Rodríguez-Rigau. New York, Raven Press, 1993, pp 253–264
  60. Cabezón C, Vigil P, Rojas I, et al. Adolescent pregnancy prevention: An abstinence-centered randomized controlled intervention in a Chilean public high school. J Adolesc Health. 2005;36:64
  61. Vigil P, Riquelme R, Rivadeneira R, et al. Effect of TeenSTAR®, an Abstinence-only Sexual Education Program on Adolescent Sexual Behavior. J Pediatr Adolesc Gynecol. 2005;18:212
  62. Vigil P, Riquelme R, Rivadeneira R, et al. TeenSTAR: Una opción de madurez y libertad. Programa de educación integral de la sexualidad, orientado a adolescentes. Rev Méd Chile. 2005;133:1173

PII: S1083-3188(06)00068-4

doi: 10.1016/j.jpag.2006.02.003

Journal of Pediatric and Adolescent Gynecology
Volume 19, Issue 3 , Pages 173-179 , June 2006